hit counter

Quetiapine-Induced Psychosis: A Rare Adverse Effect (2024 Case Report)

Quetiapine, a second-generation antipsychotic medication, is renowned for its efficacy in managing a spectrum of psychiatric conditions, including schizophrenia, bipolar disorder, and major depressive disorder (MDD). Despite its broad therapeutic utility and a generally favorable side effect profile, quetiapine’s role in rare instances of inducing psychotic symptoms warrants a closer examination. Highlights: Quetiapine’s Mechanism of …

Read more

Berberine for Depression: Mechanisms & Antidepressant Effects (2024 Review)

Depression, a pervasive global health issue, significantly impairs quality of life and burdens the healthcare system. Despite the availability of numerous antidepressants, their effectiveness is often limited, pushing researchers to explore alternative treatments. Berberine, a natural compound with a diverse pharmacological profile, has shown promising antidepressant effects, offering a potential complementary or alternative approach to …

Read more

Targeting the Nucleus Accumbens D1-MSN cAMP for Depression & Crocin’s Rapid Antidepressant Effect (2024 Study)

Depression, a debilitating mental health disorder, has long puzzled scientists and clinicians alike. Recent research sheds light on the nucleus accumbens (NAc), a brain region associated with reward and pleasure, highlighting its critical role in the pathophysiology of depression. Specifically, the study shows how manipulating cyclic adenosine monophosphate (cAMP) levels within dopamine D1 receptor medium …

Read more

Reset Modafinil Tolerance with Drug Holidays & Pitolisant-Bridging? (2023 Study)

Narcolepsy, a chronic neurological disorder, significantly impacts the daily lives of those affected due to excessive daytime sleepiness (EDS). Modafinil has been a cornerstone in managing EDS, but its effectiveness can wane over time due to tolerance. An innovative approach, using the drug pitolisant during modafinil ‘drug holidays’, offers new hope for resetting tolerance and …

Read more

Dopamine & Social Status vs. Stress Responses in Mice (2023 Study)

Social hierarchies are not just a human phenomenon; they’re prevalent in the animal kingdom too, particularly among social creatures like mice. A groundbreaking study on isogenic C57BL/6 mice has shed light on the intricate mechanisms that govern social hierarchy, particularly focusing on the role of dopamine and stress response. This discovery not only enhances our …

Read more

Proton Pump Inhibitors (PPIs) May Treat OCD via Neuronal pH & Dopamine Modulation (2024 Study)

Obsessive-compulsive disorder (OCD), a prevalent neuropsychiatric condition, presents significant treatment challenges due to its varied symptom patterns and poor response to traditional medications. Recent research has revealed a novel approach to treating OCD, focusing on the interplay between dopamine D2 receptor (D2R) agonists and proton pump inhibitors (PPIs). Highlights: OCD’s Complex Treatment Landscape: Traditional treatments …

Read more

CE-123 vs. R-Modafinil for Cognition: Dopamine Modulators (2023 Study)

Recent advancements in neuropharmacology have brought to light S-CE-123, a dopamine transporter inhibitor showing remarkable promise in cognitive enhancement. Its emergence alongside R-modafinil, a well-studied compound with a similar target, paves the way for a fascinating comparative study. This duo of compounds, entwined in the complex dance of brain chemistry, offers a glimpse into the …

Read more